BioSpace News Archive

Business

Dewpoint Therapeutics Appoints Ameet Nathwani as Chief Executive Officer

Nathwani joins Dewpoint after serving as Chief Medical Officer, Chief Digital Officer, and Executive Committee member at Sanofi

October 13, 2020
·
2 min read
Drug Development

Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, announced that it has dosed the first patients in its Phase 2 clinical trial evaluating EDP1815 for the treatment of mild to moderate psoriasis.

October 13, 2020
·
7 min read
POINT Biopharma Presents at 2020 BIO Investor ForumFirst public presentation of POINT’s radioligand platform and pipeline

POINT Biopharma Inc., a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announces its CEO, Dr. Joe McCann, will present at the 2020 BIO Investor Forum.

October 13, 2020
·
1 min read
Business

Bio-Techne To Host Conference Call On November 5, 2020 To Announce First Quarter 2021 Financial Results

Bio-Techne Corporation announced that management will host a conference call and webcast on Thursday, November 5, 2020, at 8:00 a.m. CST to review first quarter 2021 financial results.

October 13, 2020
·
2 min read
Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program

The company is advancing to scale-up and GMP batch production, to support anticipated first-in-man proof-of-concept clinical trials next year

October 13, 2020
·
6 min read
Business

Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies

Partnership Combines Twist’s Leadership in DNA Synthesis and Synthetic Biology with Neogene’s Expertise in Personalized Engineered T Cell Therapies

October 13, 2020
·
6 min read
Hemorrhagic Shock Treatment Market: Vasopressors segment witnessed significant expansion

Hemorrhagic shock is a life-threatening condition of reduced tissue perfusion, resulting in the inadequate delivery of oxygen and nutrients that are necessary for cellular function.

October 13, 2020
·
7 min read
Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer

The pre-defined disease control efficacy threshold in ovarian cancer was not met and this cohort will be closed for enrollment

October 13, 2020
·
3 min read
Deals

Abivax Secures EUR 15m Non-dilutive Financing from Kreos Capital

EUR 15m straight bonds, with no associated dilution, favorable financial conditions in interest rates and no expected transaction fees

October 13, 2020
·
7 min read
Business

Sidero Bioscience Announces Agreement with SRS Life Sciences for Commercialization of BioFe for Iron Deficiency

Sidero Bioscience, LLC, a clinical stage biotechnology company targeting human digestive health, announces the execution of a term sheet agreement with SRS Life Sciences PTE. LTD, a leading life sciences company.

October 13, 2020
·
3 min read